Search Results

There are 5233 results for: content related to: Modulation of therapeutic antibody effector functions by glycosylation engineering: Influence of Golgi enzyme localization domain and co-expression of heterologous β1, 4- N -acetylglucosaminyltransferase III and Golgi α-mannosidase II

  1. Antibody Glycosylation

    Post-translational Modification of Protein Biopharmaceuticals

    Gary Walsh, Pages: 79–108, 2009

    Published Online : 25 SEP 2009, DOI: 10.1002/9783527626601.ch4

  2. Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2009–2010

    Mass Spectrometry Reviews

    Volume 34, Issue 3, May/June 2015, Pages: 268–422, David J. Harvey

    Version of Record online : 26 MAY 2014, DOI: 10.1002/mas.21411

  3. The mast cell IgG receptors and their roles in tissue inflammation

    Immunological Reviews

    Volume 217, Issue 1, June 2007, Pages: 206–221, Odile Malbec and Marc Daëron

    Version of Record online : 7 MAY 2007, DOI: 10.1111/j.1600-065X.2007.00510.x

  4. Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion Proteins

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 6, June 2015, Pages: 1866–1884, Liming Liu

    Version of Record online : 14 APR 2015, DOI: 10.1002/jps.24444

  5. Topical distribution of FcgRI, FcgRII and FcgRIII in inflamed human gingiva

    Journal of Clinical Periodontology

    Volume 26, Issue 7, July 1999, Pages: 441–447, Zuan-Ning Yuan, Olav Schreurs, Per Gjermo, Kristen Helgeland and Karl Schenck

    Version of Record online : 16 OCT 2003, DOI: 10.1034/j.1600-051X.1999.260705.x

  6. You have free access to this content
    Both FcγRIV and FcγRIII are essential receptors mediating type II and type III autoimmune responses via FcRγ-LAT-dependent generation of C5a

    European Journal of Immunology

    Volume 39, Issue 12, December 2009, Pages: 3343–3356, Shahzad N. Syed, Stephanie Konrad, Kristina Wiege, Bernhard Nieswandt, Falk Nimmerjahn, Reinhold E. Schmidt and J. Engelbert Gessner

    Version of Record online : 30 SEP 2009, DOI: 10.1002/eji.200939884

  7. You have free access to this content
    Relevance of FcγRIIIa-158V-F polymorphism to recurrence of adult periodontitis in Japanese patients

    Clinical & Experimental Immunology

    Volume 117, Issue 2, August 1999, Pages: 350–354, Sugita, Yamamoto, Kobayashi, Van Der Pol, Horigome, Yoshie, Van De Winkel and Hara

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2249.1999.00984.x

  8. Tyrosine phosphorylation/dephosphorylation controls capping of Fcγ receptor II in U937 cells

    Cell Motility and the Cytoskeleton

    Volume 42, Issue 4, 1999, Pages: 298–314, Katarzyna Kwiatkowska and Andrzej Sobota

    Version of Record online : 2 APR 1999, DOI: 10.1002/(SICI)1097-0169(1999)42:4<298::AID-CM4>3.0.CO;2-Q

  9. You have free access to this content
    Fcγ receptor polymorphisms in systemic lupus erythematosus: Association with disease and in vivo clearance of immune complexes

    Arthritis & Rheumatism

    Volume 43, Issue 12, December 2000, Pages: 2793–2800, Hilde M. Dijstelbloem, Marc Bijl, Rob Fijnheer, Ronald H. M. Scheepers, Wia W. Oost, Marc D. Jansen, Wim J. Sluiter, Pieter C. Limburg, Ronald H. W. M. Derksen, Jan G. J. Van De Winkel and Cees G. M. Kallenberg

    Version of Record online : 26 MAR 2001, DOI: 10.1002/1529-0131(200012)43:12<2793::AID-ANR20>3.0.CO;2-6

  10. You have free access to this content
    Induction of tumor necrosis factor α production by adhered human monocytes: A key role for Fcγ receptor type IIIA in rheumatoid arthritis

    Arthritis & Rheumatism

    Volume 43, Issue 3, March 2000, Pages: 608–616, Vikki M. Abrahams, Geraldine Cambridge, Peter M. Lydyard and Jonathan C. W. Edwards

    Version of Record online : 2 APR 2001, DOI: 10.1002/1529-0131(200003)43:3<608::AID-ANR18>3.0.CO;2-G

  11. IL-3 up-regulates and activates human eosinophil CD32 and αMβ2 integrin causing degranulation

    Clinical & Experimental Allergy

    Volume 47, Issue 4, April 2017, Pages: 488–498, S. Esnault, M. W. Johansson, E. A. Kelly, L. Koenderman, D. F. Mosher and N. N. Jarjour

    Version of Record online : 23 JAN 2017, DOI: 10.1111/cea.12876

  12. You have free access to this content
    Therapeutic antibodies: successes, limitations and hopes for the future

    British Journal of Pharmacology

    Volume 157, Issue 2, May 2009, Pages: 220–233, Patrick Chames, Marc Van Regenmortel, Etienne Weiss and Daniel Baty

    Version of Record online : 28 APR 2009, DOI: 10.1111/j.1476-5381.2009.00190.x

  13. You have full text access to this OnlineOpen article
    Testing the role of the FcγRIIB immunoreceptor tyrosine-based inhibitory motif in regulation of the B cell immune response

    Immunity, Inflammation and Disease

    Volume 3, Issue 3, September 2015, Pages: 247–264, Raja Vuyyuru, Shixue Shen and Tim Manser

    Version of Record online : 4 JUN 2015, DOI: 10.1002/iid3.64

  14. Relevance of IgG receptor IIIb (CD16) polymorphism to handling of Porphyromonas gingivalis: implications for the pathogenesis of adult periodontitis

    Journal of Periodontal Research

    Volume 35, Issue 2, April 2000, Pages: 65–73, Tetsuo Kobayashi, W-Ludo Van Der Pol, Jan G. J. Van De Winkel, Kohji Hara, Noriko Sugita, Nomdo A. C. Westerdaal, Hiromasa Yoshie and Tsuneyoshi Horigome

    Version of Record online : 2 DEC 2003, DOI: 10.1034/j.1600-0765.2000.035002065.x

  15. Serum N-acetylglucosaminyltransferase III activities in hepatocellular carcinoma

    Journal of Gastroenterology and Hepatology


    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1440-1746.1998.tb00699.x

  16. You have free access to this content
    No association between neutrophil FcγRIIa allelic polymorphism and anti-neutrophil cytoplasmic antibody (ANCA)-positive systemic vasculitis

    Clinical & Experimental Immunology

    Volume 117, Issue 1, July 1999, Pages: 198–205, TSE, ABADEH, MCTIERNAN, JEFFERIS, SAVAGE and ADU

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2249.1999.00960.x

  17. N-Acetylglucosaminyltransferase V as a possible aid for the evaluation of tumor invasiveness in patients with hepatocellular carcinoma

    Journal of Gastroenterology and Hepatology

    Volume 16, Issue 11, November 2001, Pages: 1282–1289, Masahiko Yanagi, Yutaka Aoyagi, Takeshi Suda, Yuhsaku Mita and Hitoshi Asakura

    Version of Record online : 11 JAN 2002, DOI: 10.1046/j.1440-1746.2001.02612.x

  18. Engineering novel Lec1 glycosylation mutants in CHO–DUKX cells: Molecular insights and effector modulation of N-acetylglucosaminyltransferase I

    Biotechnology and Bioengineering

    Volume 109, Issue 7, July 2012, Pages: 1723–1734, Xiaotian Zhong, Cecilia Cooley, Nilufer Seth, Z. Sean Juo, Ella Presman, Nicole Resendes, Ravi Kumar, Martin Allen, Lidia Mosyak, Mark Stahl, Will Somers and Ronald Kriz

    Version of Record online : 2 FEB 2012, DOI: 10.1002/bit.24448

  19. Molecular Engineering III: Fc Engineering

    Handbook of Therapeutic Antibodies

    Matthias Peipp, Thomas Beyer, Michael Dechant, Thomas Valerius, Pages: 171–196, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch8

  20. Gene expression of N-acetylglucosaminyltransferases III and V: A possible implication for liver regeneration


    Volume 22, Issue 6, December 1995, Pages: 1847–1855, Elji Miyoshi, Yoshito Ihara, Atsushi Nishikawa, Hiroyuki Saito, Naofumi Uozumi, Norio Hayashi, Hideyuki Fusamoto, Takenobu Kamada and Naoyuki Taniguchi

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840220634